forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss GLP-1 Receptor Agonist Market Size

Semaglutide may be ideal for patients who: Prefer an established treatment option Have specific medical histories Respond well to GLP-1 medications Tirzepatide may be considered for patients who: Need more aggressive weight loss support Have significant weight loss goals May benefit from dual-hormone activation The best way to determine the right option is through a comprehensive medical evaluation

The studys authors noted that patients with type 2 diabetes often go on to develop CKD and/or heart failure due to the close relationships of those conditions

P = 0.21) (254)

Some compounded formulations have different recommended use periods